Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
about
Fisher syndrome: clinical features, immunopathogenesis and managementThe role of infections in autoimmune diseaseGuillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or VaccinationProspects for vaccine prevention of meningococcal infectionIdentification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunityAutoimmune disease triggered by infection with alphaproteobacteriaThe role of the gut microbiota in the pathogenesis of antiphospholipid syndromeSialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regenerationMolecular mimicry in pauci-immune focal necrotizing glomerulonephritisStructural and Kinetic Analysis of Substrate Binding to the Sialyltransferase Cst-II from Campylobacter jejuniMicrobe HuntingErythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy[Guillain-Barré syndrome after exposure to influenza].Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome.Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.AI-2 does not function as a quorum sensing molecule in Campylobacter jejuni during exponential growth in vitro.Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).Temperature-dependent phenotypic variation of Campylobacter jejuni lipooligosaccharidesNovel immune response to gluten in individuals with schizophreniaMechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studiesAn update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome.Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.Role of sphingolipids in microbial pathogenesisStructural heterogeneity of terminal glycans in Campylobacter jejuni lipooligosaccharides.Exposure to mimivirus collagen promotes arthritis.Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder.Development of a novel therapy for Lipo-oligosaccharide-induced experimental neuritis: use of peptide glycomimicsBioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsFlagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium.Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.Are dysregulated inflammatory responses to commensal bacteria involved in the pathogenesis of hepatobiliary-pancreatic autoimmune disease? An analysis using mice models of primary biliary cirrhosis and autoimmune pancreatitis.Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseasesComplex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling.Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis.Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.
P2860
Q22241475-25451C40-F6D9-4AF9-B8CE-C56B8F3AF471Q22242631-C8403B6D-8334-422D-A3C7-AAF273A1770EQ24276196-1C4588BA-8C03-439C-A79A-A18D443B45D2Q24537338-06148397-B064-45F2-9EF7-50DD8D5D3BE2Q24633643-38343F92-11B1-4EC5-A91F-AAE58717E770Q24655779-6C53C040-7FBE-4A77-9C11-331D3691F102Q26866133-3C357788-1E17-4622-A8D4-9BFCB4641CC2Q26995291-FBF17536-5135-4463-A534-F215D7251CBCQ27489747-2E108D26-0276-44C3-A849-5220A366C9E2Q27671666-183CF2F2-381C-4F5B-89BC-13D6B6020E92Q27890382-128E4219-C3D5-4207-B673-D4F2247F247CQ28477706-3D1F4737-4E87-47EF-B3BA-B9EEF92CA5CDQ30415924-F743C00B-0FED-4B8F-AFAA-B628A2C0BC83Q33301762-C6224573-E954-456D-9160-AF611E0A087CQ33332176-9D9D643F-B53D-432C-9E2E-EFC0242A2745Q33380490-D660E206-5E18-497F-A860-A472F0FC86B8Q33509387-1709B468-8DEF-4E05-AB72-1FC37897AD12Q33546391-01768BE3-066D-4368-B4E0-ECF5D71FEB19Q33592337-7B1EB7F3-1634-4C01-9F23-EF91247CDB37Q33605256-BA1193CB-F8DD-4A4F-AF19-DB325546C608Q33758982-4EF24DD5-7A18-4D4D-81BD-CCD35EF7BEE8Q33798660-15541DA8-5F0C-4563-956F-D92323468F76Q34127075-83FB29B5-D05E-4B26-BE59-8619C2AC18DDQ34167468-51C178A8-99D1-45C1-83E4-298932AFE7EDQ34217957-96820734-6506-466E-9773-98B7A107A398Q34300991-4DE686EC-6B04-493F-8128-C743A08837D3Q34345409-6F018630-6A28-4CEE-9985-D156BF7BBAB3Q34381319-FA6CE820-A9B2-4B27-BCCD-5B8FAE8E97E3Q34443138-EFA05243-ECA2-4DE8-9AC0-A491275D3F36Q34451647-031AED68-DA71-453D-86C9-F3808A723C6FQ34518407-F375C556-3682-48DD-ACFD-C0D16DCB03C3Q34681201-0FA858BC-920F-4D5D-BECF-793B17BDE42CQ34720405-8B96ED86-D021-46D5-AE1D-821F4864BE87Q35200720-9D65CD21-353C-4A69-9D9D-B04171AC7D3CQ35220367-3839717C-64CC-4E25-8E97-95FB101563C1Q35389058-34193457-2A10-4DF1-B163-3624D11EE037Q35547885-F3B52304-9964-4FFA-9102-41EA53203730Q35659325-A3F6FBCE-AB6C-43C9-8B1F-ECF4A0F038B7Q35674181-DAAEA1C9-06E8-41D0-AFFF-04DFF2DE78F5Q35713309-5F154CA7-3F74-48AC-8F9C-B18DDEE80EE3
P2860
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Carbohydrate mimicry between h ...... auses Guillain-Barre syndrome.
@ast
Carbohydrate mimicry between h ...... auses Guillain-Barre syndrome.
@en
type
label
Carbohydrate mimicry between h ...... auses Guillain-Barre syndrome.
@ast
Carbohydrate mimicry between h ...... auses Guillain-Barre syndrome.
@en
prefLabel
Carbohydrate mimicry between h ...... auses Guillain-Barre syndrome.
@ast
Carbohydrate mimicry between h ...... auses Guillain-Barre syndrome.
@en
P2093
P2860
P356
P1476
Carbohydrate mimicry between h ...... auses Guillain-Barre syndrome.
@en
P2093
Keiichiro Susuki
Koichi Furukawa
Koichi Hirata
Kyoji Taguchi
Masaaki Odaka
Michiaki Koga
Mitsunori Yamada
Tadashi Miyatake
Tetsuji Kobata
Yukihiro Nishimoto
P2860
P304
11404-11409
P356
10.1073/PNAS.0402391101
P407
P577
2004-07-26T00:00:00Z